Successful evaluation of the BÜHLMANN fPELA® turbo test at Synlab in Lucerne - Interview with Dr. Cyril A. Fuhrer about the successful evaluation of the BÜHLMANN fPELA® turbo test at Synlab Suisse SA in Lucerne.
BÜHLMANN anti-MAG Autoantibodies ELISA recommended by the revised Chronic Inflammatory Demyelinating Polyneuropathy 2021 guidelines - The guidelines on the diagnosis and treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) were revised by a taskforce recently. They advise anti-MAG antibody testing by means of BÜHLMANN anti-MAG Autoantibodies ELISA in all patients with an IgM paraprotein fulfilling CIDP diagnostic criteria.
BÜHLMANN highlights at ECCO 2021 - At the European Crohn’s and Colitis Organization (ECCO) 2021 congress Therapeutic Drug Monitoring (TDM) as well as remote monitoring were key topics with the ongoing pandemic forcing new ways of patient care. Of the presented abstracts, several stand out as they are using IBDoc® or BÜHLMANN’s Quantum Blue® TDM portfolio.

AACC 2021

Date: 26 – 30 September 2021
Location: Atlanta, GA, USA

2021 AACC Annual Scientific Meeting & Clinical Lab Expo. Visit our booth #3440.

UEG Week 2021

Date: 3 – 5 October 2021
Location: virtual event

29th United European Gastroenterology Week

Swiss Symposium in PoC Diagnostics 2021

Date: 21 October 2021
Location: Davos, Switzerland

4th Swiss Symposium in Point-of-Care Diagnostics


Date: 28 November – 2 December 2021
Location: Munich, Germany

24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine. Visit our booth #29.